Pharmaceuticals raises in Chicago

1 pharmaceuticals companies in Chicago filed in the last 90 days, against 0 in the 90 days before. The biggest raise on record here is Paragon Biosciences Emalex Capital, Inc. at $185M.

Companies raising per week

The last 90 days

Copy the list as CSV

First-time filers, last 90 days

Research Discovery Innovation Inc..

Everything on record

What each filing says

Beyond the amount sold, each Form D on this list states the size of the offering, how many investors had bought in when it was filed, the date of the first sale and what was sold.

• Research Discovery Innovation Inc., Form D filed 2026-07-29: an offering of $39, of which $39 was sold; 1 investor already in (1 not accredited); first sale on 2026-07-20; securities offered: equity; incorporated in Delaware; revenue range No Revenues. (source)
• OWP PHARMACEUTICALS, INC., Form D filed 2025-09-09: an offering of $2.40M, of which $2.40M was sold; 19 investors already in; first sale on 2025-07-25; securities offered: equity; incorporated in Illinois; revenue range not disclosed. (source)
• Avenacy Inc., Form D filed 2024-11-26: an offering of $34.03M, of which $26.03M was sold; 2 investors already in; first sale on 2024-11-15; securities offered: equity; incorporated in Delaware; revenue range not disclosed. (source)
• OWP PHARMACEUTICALS, INC., Form D filed 2024-09-16: an offering of $2.73M, of which $2.73M was sold; 11 investors already in; first sale on 2024-06-05; securities offered: equity; incorporated in Illinois; revenue range not disclosed. (source)
• Cosmos Health Inc., Form D filed 2023-07-27: an offering of $5.25M, of which $5.25M was sold; 3 investors already in; first sale on 2023-07-21; securities offered: equity, options or warrants; incorporated in Nevada; revenue range not disclosed. (source)
• Cosmos Health Inc., Form D filed 2022-12-21: an offering of $32.53M, of which $32.53M was sold; 0 investors already in; first sale on 2022-12-21; securities offered: equity, options or warrants; incorporated in Nevada; revenue range not disclosed. (source)
• Paragon Biosciences Emalex Capital, Inc., Form D filed 2022-11-04: an offering of $25M, of which $25M was sold; 35 investors already in; first sale on 2022-05-18; securities offered: debt, securities to be acquired on exercise; incorporated in Delaware; revenue range not disclosed. (source)
• Paragon Biosciences Emalex Capital, Inc., Form D filed 2022-11-04: an offering of $250M, of which $185M was sold; 42 investors already in; first sale on 2022-10-21; securities offered: equity; incorporated in Delaware; revenue range not disclosed. (source)

Other sectors in Chicago

AI and software Health care Retail and restaurants Computers and hardware Energy and climate Biotech Business services Manufacturing Agriculture

Pharmaceuticals in other metros

Pittsburgh Washington, DC Boston Miami New York Northern New Jersey Denver and Boulder San Francisco Bay Area Orlando and Tampa San Diego Philadelphia Raleigh-Durham Los Angeles Houston Dallas-Fort Worth Atlanta

How this list is built

Every company here filed a Form D with the SEC from this sector and metro. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.

The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.